Denmark
· Delayed Price · Currency is DKK BioPorto Statistics
Total Valuation
BioPorto has a market cap or net worth of DKK 792.29 million. The enterprise value is 694.10 million.
| Market Cap | 792.29M |
| Enterprise Value | 694.10M |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BioPorto has 429.66 million shares outstanding. The number of shares has increased by 15.17% in one year.
| Shares Outstanding | 429.66M |
| Shares Change (YoY) | +15.17% |
| Shares Change (QoQ) | +4.32% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 4.65% |
| Float | 352.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.71 |
| PB Ratio | 6.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.88 |
| EV / Sales | 20.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.39 |
Financial Position
The company has a current ratio of 5.35, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.35 |
| Quick Ratio | 5.06 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -85.70 |
Financial Efficiency
Return on equity (ROE) is -53.82% and return on invested capital (ROIC) is -34.24%.
| Return on Equity (ROE) | -53.82% |
| Return on Assets (ROA) | -28.19% |
| Return on Capital (ROIC) | -34.24% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | -1.85M |
| Employee Count | 29 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 3.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.36% in the last 52 weeks. The beta is 1.25, so BioPorto's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +19.36% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 1.88 |
| Relative Strength Index (RSI) | 36.84 |
| Average Volume (20 Days) | 346,606 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioPorto had revenue of DKK 33.83 million and -50.02 million in losses. Loss per share was -0.13.
| Revenue | 33.83M |
| Gross Profit | 24.28M |
| Operating Income | -54.93M |
| Pretax Income | -55.38M |
| Net Income | -50.02M |
| EBITDA | -54.10M |
| EBIT | -54.93M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 103.91 million in cash and 5.72 million in debt, giving a net cash position of 98.19 million or 0.23 per share.
| Cash & Cash Equivalents | 103.91M |
| Total Debt | 5.72M |
| Net Cash | 98.19M |
| Net Cash Per Share | 0.23 |
| Equity (Book Value) | 104.82M |
| Book Value Per Share | 0.26 |
| Working Capital | 100.71M |
Cash Flow
In the last 12 months, operating cash flow was -55.99 million and capital expenditures -39,000, giving a free cash flow of -56.03 million.
| Operating Cash Flow | -55.99M |
| Capital Expenditures | -39,000 |
| Free Cash Flow | -56.03M |
| FCF Per Share | -0.13 |
Margins
Gross margin is 71.76%, with operating and profit margins of -162.38% and -147.84%.
| Gross Margin | 71.76% |
| Operating Margin | -162.38% |
| Pretax Margin | -163.71% |
| Profit Margin | -147.84% |
| EBITDA Margin | -159.91% |
| EBIT Margin | -162.38% |
| FCF Margin | -165.62% |
Dividends & Yields
BioPorto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.17% |
| Shareholder Yield | -15.17% |
| Earnings Yield | -7.14% |
| FCF Yield | -7.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |